1. Home
  2. UMH vs IOVA Comparison

UMH vs IOVA Comparison

Compare UMH & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UMH

UMH Properties Inc.

HOLD

Current Price

$15.96

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.85

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UMH
IOVA
Founded
1968
2007
Country
United States
United States
Employees
513
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
968.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UMH
IOVA
Price
$15.96
$2.85
Analyst Decision
Strong Buy
Buy
Analyst Count
4
12
Target Price
$17.75
$10.45
AVG Volume (30 Days)
602.7K
11.3M
Earning Date
11-03-2025
11-06-2025
Dividend Yield
5.64%
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$256,272,000.00
$250,425,000.00
Revenue This Year
$10.80
$60.71
Revenue Next Year
$8.34
$59.52
P/E Ratio
$203.36
N/A
Revenue Growth
8.96
175.62
52 Week Low
$13.95
$1.64
52 Week High
$19.14
$8.15

Technical Indicators

Market Signals
Indicator
UMH
IOVA
Relative Strength Index (RSI) 60.23 69.24
Support Level $15.58 $2.08
Resistance Level $16.39 $2.60
Average True Range (ATR) 0.28 0.17
MACD -0.01 0.07
Stochastic Oscillator 69.47 87.36

Price Performance

Historical Comparison
UMH
IOVA

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: